Why Certain Healthcare Categories Remain Underbuilt

Healthcare innovation tends to cluster around categories that are easy to explain, easy to finance, or temporarily fashionable. Yet some of the most interesting opportunities remain in markets that are clinically important, commercially meaningful, and still surprisingly underbuilt. These are not necessarily small or obscure markets. Often they are categories with real demand that have historically been underserved because they involve stigma, fragmented buyers, difficult workflows, unclear champions, or years of strategic neglect. Understanding why they remain underbuilt is useful because it often reveals where thoughtful company building can still create durable value.

One reason categories stay underbuilt is structural complexity. Some markets require the company to serve multiple stakeholders at once, work through diffuse care pathways, or prove value in settings where reimbursement and buying authority are fragmented. That can be discouraging for undisciplined capital or generic startup playbooks. But complexity can also create opportunity. It can repel shallow entrants while leaving room for companies that are willing to understand the category deeply and build in a more patient, strategic way.

Another reason is cultural underinvestment. Women's health offers a clear example, but it is not the only one. Categories tied to quality of life, chronic burden, stigma, or less visible patient populations have often been treated as secondary even when the need is large. In some cases, the market did not lack a problem; it lacked seriousness. As a result, the companies that do emerge in these spaces can find meaningful whitespace if they combine category empathy with disciplined execution and clear commercialization.

Underbuilt categories also require a sharper understanding of the customer. In many such markets, the user, beneficiary, buyer, and champion are not the same person. The product may need to solve a clinical problem, an access problem, an education problem, and an implementation problem simultaneously. Companies that succeed here usually understand the lived reality of the customer unusually well. They recognize not only the need itself, but the reasons previous solutions failed to become part of routine care or consumer behavior.

For investors, these categories can be compelling precisely because they are misunderstood. They may not fit neat pattern-recognition heuristics, but that can mean the market has not yet fully organized around them. In our view, the goal is to distinguish between categories that are underbuilt because they are unattractive and those that are underbuilt because they have been underestimated. The latter often reward businesses that pair real insight with operational discipline.

Totipotent is drawn to the latter group. We like companies that bring clarity to markets where the demand is real but the solution set remains thin, fragmented, or poorly designed. In healthcare, enduring value is often created not by chasing the loudest category, but by understanding a neglected one well enough to build it properly. That is still one of the clearest ways differentiated company building happens.